Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Ager

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Nature Immunology|January 22, 2020
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1Michael D Crowther, Garry Dolton, Mateusz Legut, et al.
Med (New York, N.Y.)|May 19, 2022
LRG1 destabilizes tumor vessels and restricts immunotherapeutic potencyMarie N O'Connor, David M Kallenberg, Carlotta Camilli, et al.
Scientific Reports|April 4, 2019
ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cellsRebar N Mohammed, Sophie C Wehenkel, Elena V Galkina, et al.
The Journal of Clinical Investigation|March 13, 2018
Peptide mimic for influenza vaccination using nonnatural combinatorial chemistryJohn J Miles, Mai Ping Tan, Garry Dolton, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus StatementEmma Short, Ian M Adcock, Bilal Al-Sarireh, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Nature Immunology|January 22, 2020
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1Michael D Crowther, Garry Dolton, Mateusz Legut, et al.
Med (New York, N.Y.)|May 19, 2022
LRG1 destabilizes tumor vessels and restricts immunotherapeutic potencyMarie N O'Connor, David M Kallenberg, Carlotta Camilli, et al.
Scientific Reports|April 4, 2019
ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cellsRebar N Mohammed, Sophie C Wehenkel, Elena V Galkina, et al.
The Journal of Clinical Investigation|March 13, 2018
Peptide mimic for influenza vaccination using nonnatural combinatorial chemistryJohn J Miles, Mai Ping Tan, Garry Dolton, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus StatementEmma Short, Ian M Adcock, Bilal Al-Sarireh, et al.
Pageof 5